Skip to main content
SpringerLink
Log in

Targeting of Drug to the Hepatocytes by Fatty Acids. Influence of the Carrier (Albumin or Galactosylated Albumin) on the Fate of the Fatty Acids and Their Analogs

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The aim of this study was to evaluate the potential of fatty acids as shuttles to deliver xenobiotic inside the hepatocytes as well as to study the mechanism of incorporation into isolated hepatocytes when bound to native albumin or galactosylated albumin. Theoretically, they can enter into the hepatocytes after recognition of the Fatty Acid Binding Protein (FABPPM), or remain bound to galactosylated proteins and enter into these cells by a process known as receptor mediated endocytosis after selective recognition of the asialoglycoprotein receptor (ASGPR).

Methods. We synthesized a 3H-benzoyl adduct of lauric acid (BLA) (benzoyl adduct choosen to mimick any low molecular weight drug or contrast agent), and compared the behavior of BLA with oleic acid for their binding properties to carrier-proteins and the uptake mechanism by isolated hepatocytes.

Results. No significant difference was found in the binding properties of BLA for albumin and galactosylated albumin. The incorporation into the hepatocytes was found essentially depending on the FABPPM transport system whenever BLA was bound to albumin or to galactosylated albumin in the incubation medium: indeed, the transport was inhibited by phloretin (inhibitor of sodium dependent transport), increased when the free part of BLA was higher, and BLA was recovered in the cytosolic fraction of the hepatocytes.

Conclusions. This study showed the convenience in using fatty acids as drug carriers possessing tropism for the hepatocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. B. Gallez, R. Debuyst, R. Demeure, F. Dejehet, C. Grandin, B. Van Beers, H. Taper, J. Pringot, P. Dumont. Evaluation of a nitroxyl fatty acid as liver contrast agent for magnetic resonance imaging. Magn. Reson. Med. 30: 592–599 (1993).

    Google Scholar 

  2. B. Gallez, V. Lacour, R. Demeure, R. Debuyst, F. Dejehet, J.L. De Keyser, P. Dumont. Spin labelled arabinogalactan as MRI contrast agent. Magn. Reson. Imag. 12: 61–69 (1994).

    Google Scholar 

  3. W. Stremmel, H. Kleinert, A. Fitsher, J. Gunawan, C. Klaassen-Schlüter, K. Moller, M. Wegener. Mechanisms of cellular fatty acid uptake. Biochem. Soc. Trans. 20: 814–817 (1993).

    Google Scholar 

  4. Y.C. Lee. Biochemistry of carbohydrate-protein interaction. FASEB J. 6: 3193–3200 (1992).

    Google Scholar 

  5. D. Hesk, J.R. Jones, W.J.S. Lockley. Regiospecific deuteriation and tritiation of various drugs using a homogeneous rhodium chloride catalyst. J. Pharm. Sci. 80: 887–890 (1991).

    Google Scholar 

  6. B.A. Schwartz, G.R. Gray. Proteins containing reductively aminated disaccharides. Synthesis and chemical characterization. Arch. Biochem. Biophys. 181: 542–549 (1977).

    Google Scholar 

  7. G. Krack, O. Gravier, M. Roberfroid, M. Mercier. Subcellular fractionation of isolated rat hepatocytes. A comparison with liver homogenate. Biochim. Biophys. Acta 632: 619–629 (1980).

    Google Scholar 

  8. N.A. Abumrad, C. Perkins, J.H. Park, C.R. Park. Mechanisms of long-chain fatty acid permeation in the isolate hepatocyte. J. Biol. Chem. 256, 9183–9191 (1981).

    Google Scholar 

  9. C. De Duve. Principles of tissue fractionation. J. Theroret. Biol. 6: 33–69 (1964).

    Google Scholar 

  10. B. Gallez, J.L. De Keyser, R. Debuyst, F. Dejehet, L. Neuvens, P. Dumont. The effects of pasteurisation on albumin: An EPR binding assay for polymeric albumin. J. Pharm. Biomed. Anal. in press.

  11. F. Atlasovich, J.A. Santome, H.N. Fernandez. Photoreactive fatty acid analogs that bind to the rat liver fatty acid-binding protein: 11-(5′-azido-salicylamido)-undecanoic acid derivatives. Mol. Cell. Biochem. 120: 15–23 (1993).

    Google Scholar 

  12. R. Zimmermann, B. Rauch, M. Kapp, B. Bubeck, F.J. Neumann, F. Seitz, P. Stockad, G. Mall, H. Tillmanns, W. Kubler. Myocardial scintigraphy with iodine-123 phenylpentadecanoic acid and thallium-201 in patients with coronary artery disease: a comparative dual-isotope study. Eur. J. Nucl. Med. 19, 946–954 (1992).

    Google Scholar 

  13. Y. Fujibayashi, P. Som, Y. Yonekura, F.F. Knapp, N. Tamaki, K. Yamamoto, J. Konishi, A. Yokoyama. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analog, [125I](piodophenyl)-3-(R,S)-methylpentadecanoic acid (BMIPP), and correlation to ATP concentration. II. Studies in salt-induced hypertensive rats. Nucl. Med. Biol. 20: 163–166 (1993).

    Google Scholar 

  14. H.J. Machulla, E.J. Knust. Recent developments in the field of 123I-radiopharmaceuticals. Nuklearmedizin 23: 111–118 (1984).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, Laboratory of Medicinal Chemistry, Catholic University of Louvain, Avenue Mounier 73, B-1200, Brussels, Belgium

    Vinciane Charbon, Didier M. Lambert, Laurence Neuvens, Jean-Luc De Keyser & Bernard Gallez

  2. Department of Pharmaceutical Sciences, Laboratory of Toxicologic and Cancerologic Biochemistry, Catholic University of Louvain, Avenue Mounier 73, B-1200, Brussels, Belgium

    Isabella Latour & Pedro Buc-Calderon

Authors
  1. Vinciane Charbon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Isabella Latour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Didier M. Lambert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pedro Buc-Calderon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Laurence Neuvens
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jean-Luc De Keyser
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bernard Gallez
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Charbon, V., Latour, I., Lambert, D.M. et al. Targeting of Drug to the Hepatocytes by Fatty Acids. Influence of the Carrier (Albumin or Galactosylated Albumin) on the Fate of the Fatty Acids and Their Analogs. Pharm Res 13, 27–31 (1996). https://doi.org/10.1023/A:1016012913664

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016012913664

Search

Navigation